ABCM Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 дек. 2023 @ 00:00):

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery...

Stats
Объем за сегодня	7.43M
Средний объем	5.82M
Рыночная капитализация	5.52B
EPS	£0.0361 ( 2023-08-31 )
Last Dividend	£0.0443 ( 2020-03-19 )
Next Dividend	£0 ( N/A )
P/E	2 399.00
ATR14	£0.166 (0.69%)

Объем Корреляция

Длинно: -0.08 (neutral)

Кратко: 0.00 (neutral)

Signal:(73.195) Neutral

Abcam plc Корреляция

10 Самые положительные корреляции
ALGT	0.963
MSAC	0.953
MLAI	0.95
KAII	0.95
QUIK	0.947
CAR	0.946
GGAL	0.944
BTBT	0.944
ALSA	0.943
LGAC	0.943

10 Самые отрицательные корреляции
PRPO	-0.962
PSCH	-0.955
PSCC	-0.942
VORB	-0.942
PRFZ	-0.938
VIVE	-0.938
PTH	-0.937
ORPH	-0.935
PNQI	-0.935
SENEA	-0.932

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Abcam plc Корреляция - Валюта/Сырье

-0.38
( neutral )

-0.56
( weak negative )

0.00
( neutral )

-0.61
( weak negative )

0.28
( neutral )

0.50
( neutral )

Abcam plc Финансовые показатели

Annual	2022
Выручка:	£361.70M
Валовая прибыль:	£270.50M (74.79 %)
EPS:	£-0.0372

FY	2022
Выручка:	£361.70M
Валовая прибыль:	£270.50M (74.79 %)
EPS:	£-0.0372

FY	2021
Выручка:	£297.70M
Валовая прибыль:	£211.80M (71.15 %)
EPS:	£0.0780

Financial Reports:

No articles found.

Abcam plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Abcam plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.72 - No dividend growth expected in the near future

Information

First Dividend	£0.0358	2014-03-19
Last Dividend	£0.0443	2020-03-19
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	£0.836	--
Avg. Dividend % Per Year	0.02%	--
Score	3.14	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.72
Div. Directional Score	6.68	--

Next Divdend (Est)
(2024-08-19)

£0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

3.14

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2014	£0.122	1.59%
2015	£0.124	1.78%
2016	£0.117	1.23%
2017	£0.114	1.26%
2018	£0.158	1.12%
2019	£0.157	1.10%
2020	£0.0443	0.24%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.000600	1.500	9.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0.000268	1.200	9.99	10.00	[0 - 0.3]
returnOnEquityTTM	0.000380	1.500	-1.107	-1.660	[0.1 - 1]
payoutRatioTTM	22.73	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.354	0.800	8.23	6.58	[1 - 3]
quickRatioTTM	0.993	0.800	8.86	7.09	[0.8 - 2.5]
cashRatioTTM	0.418	1.500	8.79	10.00	[0.2 - 2]
debtRatioTTM	0.211	-1.500	6.48	-9.72	[0 - 0.6]
interestCoverageTTM	9.21	1.000	7.70	7.70	[3 - 30]
operatingCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.302	-1.500	8.79	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.779	1.000	0.352	0.352	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.121	1.000	-0.440	-0.440	[0.2 - 2]
assetTurnoverTTM	0.446	0.800	-0.360	-0.288	[0.5 - 2]
Total Score				10.65

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	16 247	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.000380	2.50	-0.712	-1.660	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.113	2.00	9.96	10.00	[0 - 30]
payoutRatioTTM	22.73	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-761.25	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0572	1.000	-1.070	0	[0.1 - 0.5]
Total Score				2.72

Abcam plc

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.